Dating back to early 2020, the
ARK 3D Printing ETF (CBOE: PRNT) is on a torrid pace, one that’s being facilitated by industrial 3D printing.
PRNT is the first US-listed ETF dedicated to the 3D printing theme. The fund is one of two passively managed products from New York-based Ark Investment Management. ARK believes 3D printing will revolutionize manufacturing by collapsing the time between design and production, reducing costs, and enabling greater design complexity, accuracy, and customization than traditional manufacturing.
Healthcare is one of the most fertile territories for 3D printing. New frontiers are emerging in the arena.
“The FDA has approved its first 3D printed talus metal implant designed to replace the main bone in the ankle joint connecting the leg to the foot. The agency issued a green light to New Jersey-based Additive Orthopaedics under humanitarian use for the treatment of avascular necrosis, a progressive condition that can lead to the death of bone t